Solana Co

Solana Co(HSDT)股票分析

$1.930

-0.156 (-8.10%)收盘时

Loading chart…
最高
2.100
开盘
2.100
成交量加权均价
1.96
成交量
601.53K
市值
2.91M
最低
1.850
成交额
1.18M
企业价值/息税折旧摊销前利润(TTM)
-0.75

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

AI 分析 of Solana Co (HSDT)

卖出

Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.

分析师评级(1)

买入
1 买入
0 持有
0 卖出
当前: 1.93
最低
—
平均
—
最高
—

B. Riley

2026-09-22

目标价

$4

买入

B. Riley

2026-09-03

目标价

—

买入

B. Riley

2026-04-23

目标价

$3

买入

Maxim Group

2024-10-16

目标价

—

持有

Roth MKM

2024-03-05

目标价

$24

强烈买入

估值指标

Solana Co(HSDT)当前预期市盈率为 0.00,5 年平均预期市盈率为 -2.35。

预期市盈率

合理
5 年均值 P/E
-2.35
当前P/E
0.00
高估
4.42
低估
-9.13

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-0.93
当前EV/EBITDA
-0.75
高估
12.80
低估
-14.66

预期市销率

合理
5 年均值 P/S
48.77
当前P/S
9.87
高估
224.58
低估
-127.04

Alphio AI 对 HSDT 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HSDT

$2.58

情景价格

基

基准

基准 · 50%HSDT

$2.40

情景价格

悲

悲观

悲观 · 25%HSDT

$2.06

情景价格

持有 HSDT 的大户

V

VR Advisory Services Ltd.

+ 持有HSDT

+0.00%

3个月收益率

事件时间线

2026-10-23 (ET)

10:00:00

Webull to Launch Crypto-Linked Perpetual Futures in November

2026-10-22 (ET)

09:30:00

Solana Company Designated as Strategic Enterprise by Hong Kong Government

2026-09-25 (ET)

10:00:00

Binance Invests $100M in Circle to Boost USDC Development

2026-09-04 (ET)

10:30:00

Coinbase Files for U.S. Derivatives Registration

2026-06-30 (ET)

07:30:00

Solana Signs MoU with Alatau City for Blockchain Partnership

资讯

HSDT 常见问题 —— 由 Alphio AI 解答

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.

1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易